Celldex Therapeutics, Inc. (CLDX) Presents at Morgan Stanley 23rd

Core Viewpoint - The session at the Morgan Stanley Global Healthcare Conference features the Celldex team, focusing on their company background and lead asset [1][2]. Company Background - Celldex is being introduced to attendees who may not be familiar with the company and its operations [2]. Lead Asset - The discussion will include details about Celldex's lead asset, which is a significant focus for the company [2].